1-5 of 5
Richard Klasa, MD, CM
Close
Sort by
Journal Articles

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Laurie H Sehn, MD MPH, Edward L G Hardy, MD FRCPC, Karamjit K Gill, MD FRCPC, Abdulwahab J Al-Tourah, MBChB, FRCPC, Jesse Shustik, MD, Nicol A Macpherson, MDPhDFRCPC,, Adrian Yee, MD FRCPC, Wendy Lam, MD, Kerry J. Savage, MD MSc, Richard Klasa, MD CM, FRCP(C), Diego Villa, MDMPH, Alina S Gerrie, MD, Tamara Shenkier, MD, Graham W Slack, MD, Randy D. Gascoyne, MD, Francois Benard, MD, Don Wilson, MD, Peter Tonseth, MD, Joseph M Connors, MD
Journal: Blood
Blood (2014) 124 (21): 392.
https://doi.org/10.1182/blood.V124.21.392.392
Published: 2014
Journal Articles

Diffuse Large B-Cell Lymphoma with Testicular Involvement: Outcome and Risk of CNS Relapse in the Rituximab Era

David Telio, MD, Diego Villa, MD, MPH, Tamara Shenkier, MD, Laurie H. Sehn, MD, MPH, Richard Klasa, MD, CM, King Tan, MBBS, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Kerry J. Savage, MD MSc
Journal: Blood
Blood (2011) 118 (21): 780.
https://doi.org/10.1182/blood.V118.21.780.780
Published: 2011
Journal Articles

Hodgkin Lymphoma Patients with Stage II B or Stage II Bulky Disease Have Advanced Disease and Should Not Be Included In Limited Stage Trials

Joseph M. Connors, MD, Randy D. Gascoyne, MD, Paul Hoskins, MD, James Morris, MD, Tom Pickles, MD, FRCPC, Laurie Sehn, MD, MPH, Tamara Shenkier, MD, Richard Klasa, MD, CM, FRCP(C), Nicholas Voss, MD, Kerry Joanne Savage, MD, BSc, MSc
Journal: Blood
Blood (2010) 116 (21): 417.
https://doi.org/10.1182/blood.V116.21.417.417
Published: 2010
Journal Articles

Outcome of Patients with Chemotherapy Refractory and Early Progressive Diffuse Large B Cell Lymphoma After R-CHOP Treatment

Felicitas Hitz, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Paul Hoskins, Alden A. Moccia, Kerry Joanne Savage, MD, BSc, MSc, Laurie H. Sehn, MD, MPH, Tamara Shenkier, Richard Klasa, MD, CM, FRCP(C)
Journal: Blood
Blood (2010) 116 (21): 1751.
https://doi.org/10.1182/blood.V116.21.1751.1751
Published: 2010
Journal Articles

Results of a Pivotal Phase 2 Study of Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Hodgkin Lymphoma

Robert Chen, Ajay K. Gopal, MD, Scott E. Smith, MD, PhD, FACP, Stephen M. Ansell, MD, PhD, Joseph D. Rosenblatt, MD, Richard Klasa, MD, CM, FRCP(C), Joseph M. Connors, MD, Andreas Engert, MD, Emily K. Larsen, MS, Dana A. Kennedy, PharmD, Eric L. Sievers, MD, Anas Younes, MD
Journal: Blood
Blood (2010) 116 (21): 283.
https://doi.org/10.1182/blood.V116.21.283.283
Published: 2010